Accessibility and adherence to positive airway pressure treatment in patients with obstructive sleep apnea: a multicenter study in Latin America.


Journal

Sleep & breathing = Schlaf & Atmung
ISSN: 1522-1709
Titre abrégé: Sleep Breath
Pays: Germany
ID NLM: 9804161

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 14 03 2019
accepted: 18 06 2019
revised: 15 05 2019
pubmed: 27 6 2019
medline: 17 12 2021
entrez: 27 6 2019
Statut: ppublish

Résumé

Information on access and adherence to positive airway pressure (PAP) treatment is lacking at the regional level in Latin America. This study characterized access and adherence to PAP in patients with moderate-severe obstructive sleep apnea (OSA) in Latin America. Cross-sectional study, conducted at 9 sleep centers across Argentina, Brazil, Chile, Colombia, Mexico, and Peru. Adults diagnosed with moderate-severe OSA (apnea-hypopnea index [AHI] ≥ 15/h) in the previous 12-18 months were eligible. Anthropometrics, health coverage, and OSA severity data were collected. Data on access to therapy, barriers to access, adherence, and factors related to non-compliance were obtained via standardized telephone survey. Eight hundred eighty patients (70% male, 54 ± 13 years, AHI 49 ± 28/h, body mass index 32 ± 7 kg/m Less than half moderate-severe OSA patients started and continue to use PAP. Unclear or absent medical indication and financial limitations were the most relevant factors limiting access to therapy.

Identifiants

pubmed: 31240542
doi: 10.1007/s11325-019-01881-9
pii: 10.1007/s11325-019-01881-9
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

455-464

Subventions

Organisme : Associação Fundo de Incentivo à Pesquisa
ID : 309336/2017-1

Auteurs

Juan Facundo Nogueira (JF)

Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina. dr.facundo.nogueira@gmail.com.

Dalva Poyares (D)

Universidade Federal de São Paulo-SP, São Paulo, Brazil.

Guido Simonelli (G)

Behavioral Biology Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA.

Sebastián Leiva (S)

Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina.

José Luis Carrillo-Alduenda (JL)

Instituto Nacional de Enfermedades Respiratorias (INER), Ciudad de México, Mexico.

María Angélica Bazurto (MA)

Fundación Neumológica Colombiana, Bogotá, Colombia.

Guadalupe Terán (G)

Universidad Autónoma Metropolitana (UAM), Ciudad de México, Mexico.

Matilde Valencia-Flores (M)

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.

Leonardo Serra (L)

Clínica Alemana, Universidad del Desarrollo, Santiago, Chile.

Jorge Rey de Castro (JR)

Clínica Anglo Americana, Univ. Peruana Cayetano Heredia, Lima, Peru.

Victoria Santiago-Ayala (V)

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico.

Daniel Pérez-Chada (D)

Hospital Austral, Universidad Austral, Buenos Aires, Argentina.

María Eugenia Franchi (ME)

Hospital Austral, Universidad Austral, Buenos Aires, Argentina.

Ligia Lucchesi (L)

Universidade Federal de São Paulo-SP, São Paulo, Brazil.

Sergio Tufik (S)

Universidade Federal de São Paulo-SP, São Paulo, Brazil.

Lia Bittencourt (L)

Universidade Federal de São Paulo-SP, São Paulo, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH